Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Filings indexed 162 across all filing types
Latest filing 2023-12-15 Regulatory Filings
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of a corporate action related to shareholder rights. Given it is a standard regulatory notification regarding meeting preparation, it falls under the RNS category.
2023-12-15 Korean
기타주요경영사항(자율공시)(품목허가취소 등 행정처분 취소소송 판결)
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a court ruling on an administrative litigation involving product license cancellation and manufacturing suspension. It details the legal case, the court's decision, and the impact on the company's operations. This falls under the category of legal proceedings and regulatory actions involving the company.
2023-12-11 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a formal notification regarding the results of an Investor Relations (IR) event held by PharmaResearchBio. It lists the date, location, attendees, and a summary of the topics discussed (Q3 2023 performance review and company introduction). Since this is a short regulatory announcement confirming that an IR event took place and providing the date/location, rather than the actual presentation slides or a full financial report, it falls under the category of a general regulatory filing or announcement of an event.
2023-11-23 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into the specific report categories, it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure notice.
2023-11-09 Korean
신규시설투자등
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from PharmaResearchBio regarding a 'New Facility Investment' (신규 시설투자). It details the investment amount, purpose (factory expansion), and timeline, which is a standard corporate disclosure for capital expenditure. Since it does not fit into specific categories like M&A, dividends, or share repurchases, and is a formal regulatory disclosure of a material event, it is classified as a Regulatory Filing (RNS).
2023-09-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (such as gifts and market purchases), and share counts. This falls under the category of Major Shareholding Notification.
2023-09-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.